[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600948":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":27,"centralContacts":33,"locations":41,"responsibleParty":80,"collaborators":82,"id":86,"slug":87,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":92,"eligibilityCriteria":93,"healthyVolunteers":88,"sex":94,"minAge":95,"maxAge":11,"enrollmentInfo":96,"targetDuration":11,"studyType":99,"phases":100,"briefSummary":102,"conditions":103,"keywords":11,"overallStatus":65,"whyStopped":11,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Washington University School of Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Social drivers of health screening","EXPERIMENTAL",null,[13],"Other: Social drivers of health screening",{"label":15,"type":10,"description":11,"interventionNames":16},"Contingency Management",[17],"Behavioral: Patients will undergo a program of contingency management",[19,22],{"type":6,"name":9,"description":20,"armGroupLabels":21,"otherNames":11},"Patients will undergo a structured and protocoled screening for social drivers of health and be linked to support services",[9],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":11},"BEHAVIORAL","Patients will undergo a program of contingency management","Patients will enter into a 12 week program of contingency management",[15],[28,31],{"name":29,"affiliation":5,"role":30},"Jeannie C Kelly, MD, MS","PRINCIPAL_INVESTIGATOR",{"name":32,"affiliation":5,"role":30},"Ana Baumann Walker, PhD, MA",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":11,"email":38},"Melissa M Mills, BS","CONTACT","314-273-2279","melissa.mills@wustl.edu",{"name":29,"role":36,"phone":11,"phoneExt":11,"email":40},"jckelly@wustl.edu",[42,63],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"University of Maryland","NOT_YET_RECRUITING","Baltimore","Maryland","21201","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-76.61219,39.29038,{"lat":54,"lon":53},[57,61],{"name":58,"role":36,"phone":59,"phoneExt":11,"email":60},"Makeda Turner","443-328-4738","Makeda.Turner@som.umaryland.edu",{"name":62,"role":30,"phone":11,"phoneExt":11,"email":11},"Courtney Townsel, MD, MSc",{"facility":64,"status":65,"city":66,"state":67,"zip":68,"country":48,"countryCode":49,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Washington University","RECRUITING","St Louis","Missouri","63108",{"type":51,"coordinates":70},[71,72],-90.19789,38.62727,{"lat":72,"lon":71},[75,77,78],{"name":76,"role":36,"phone":37,"phoneExt":11,"email":38},"Melissa Mills",{"name":29,"role":30,"phone":11,"phoneExt":11,"email":11},{"name":79,"role":30,"phone":11,"phoneExt":11,"email":11},"Ana Baumann Walker, PhD",{"type":81,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[83],{"name":84,"class":85},"National Institute on Drug Abuse (NIDA)","NIH","100600948","substance-use-in-pregnant-people---optimizing-retention-in-treatment-100600948",false,"NCT07104123","Substance Use in Pregnant People - Optimizing Retention in Treatment","Substance Use in Pregnant People - Optimizing Retention in Treatment by Maximizing Opportunities for Management","SUPPORT-MOM","Inclusion Criteria:\n\nConfirmed viable intrauterine pregnancy at any gestational age, or within three years postpartum\n\nSUD as defined in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders or clinician documentation\n\nExclusion Criteria:\n\nDecline follow-up care at study site\n\nRequire immediate hospitalization for unstable medical or psychiatric conditions making them clinically unsuitable to participate in a research study","FEMALE","18 Years",{"count":97,"type":98},40,"ESTIMATED","INTERVENTIONAL",[101],"NA","Substance use during pregnancy is a leading cause of maternal morbidity and mortality in the United States, with 55-80% of postpartum patients disengaging from substance use disorder (SUD) treatment within one year of delivery. Structural and social determinants of health, including housing instability, transportation barriers, and limited childcare access, further exacerbate disparities in treatment retention.\n\nThis pilot study, conducted in two specialized prenatal care clinics, evaluates the feasibility and acceptability of two integrated strategies to promote sustained engagement in recovery-oriented services during the perinatal and postpartum periods. Aim 1 implements a standardized social needs screening and referral protocol to connect patients with community-based supports. Aim 2 pilots a contingency management intervention to incentivize recovery-supportive behaviors.\n\nFindings will inform the design of a larger multi-site randomized controlled trial to evaluate the impact of these interventions on treatment retention, overdose prevention, and maternal-infant health outcomes.",[104,105,106,15],"Substance Use Disorder (SUD)","Pregnancy","Postpartum","2026-06-17",{"date":109,"type":110},"2026-06-22","ACTUAL",{"date":112,"type":110},"2026-02-02",{"date":114,"type":98},"2027-09",{"name":5,"class":6},2]